Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Verotta

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|April 29, 2015
New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilmsJanus A J Haagensen, Davide Verotta, Liusheng Huang, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilmsJanus Haagensen, Davide Verotta, Liusheng Huang, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 17, 2008
Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tabletsLudwig Perger, Katharina M Rentsch, Gerd A Kullak-Ublick, et al.
British Journal of Clinical Pharmacology|March 9, 2005
A predictive model for exemestane pharmacokinetics/pharmacodynamics incorporating the effect of food and formulationMarta Valle, Enrico Di Salle, Maria Gabriella Jannuzzo, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 28, 2006
Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteriaSmita A Kshirsagar, Terrence F Blaschke, Lewis B Sheiner, et al.
Anesthesiology|October 3, 2002
Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteersDavid R Drover, Martin S Angst, Marta Valle, et al.
Clinical Pharmacology and Therapeutics|January 25, 2003
Population analyses of sustained-release verapamil in patients: effects of sex, race, and smokingDongwoo Kang, Davide Verotta, Mary Ellen Krecic-Shepard, et al.
Journal of Analytical Methods in Chemistry|June 2, 2018
Determination of Tobramycin in M<sub>9</sub> Medium by LC-MS/MS: Signal Enhancement by Trichloroacetic AcidLiusheng Huang, Janus Anders Juul Haagensen, Davide Verotta, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 2011
A method to quantify illicit intake of drugs from urine: methamphetamineLinghui Li, Gantt P Galloway, Davide Verotta, et al.
AIDS (London, England)|February 4, 2012
Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African womenBetty J Dong, Yu Zheng, Michael D Hughes, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|April 29, 2015
New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilmsJanus A J Haagensen, Davide Verotta, Liusheng Huang, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilmsJanus Haagensen, Davide Verotta, Liusheng Huang, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 17, 2008
Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tabletsLudwig Perger, Katharina M Rentsch, Gerd A Kullak-Ublick, et al.
British Journal of Clinical Pharmacology|March 9, 2005
A predictive model for exemestane pharmacokinetics/pharmacodynamics incorporating the effect of food and formulationMarta Valle, Enrico Di Salle, Maria Gabriella Jannuzzo, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 28, 2006
Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteriaSmita A Kshirsagar, Terrence F Blaschke, Lewis B Sheiner, et al.
Anesthesiology|October 3, 2002
Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteersDavid R Drover, Martin S Angst, Marta Valle, et al.
Clinical Pharmacology and Therapeutics|January 25, 2003
Population analyses of sustained-release verapamil in patients: effects of sex, race, and smokingDongwoo Kang, Davide Verotta, Mary Ellen Krecic-Shepard, et al.
Journal of Analytical Methods in Chemistry|June 2, 2018
Determination of Tobramycin in M<sub>9</sub> Medium by LC-MS/MS: Signal Enhancement by Trichloroacetic AcidLiusheng Huang, Janus Anders Juul Haagensen, Davide Verotta, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 2011
A method to quantify illicit intake of drugs from urine: methamphetamineLinghui Li, Gantt P Galloway, Davide Verotta, et al.
AIDS (London, England)|February 4, 2012
Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African womenBetty J Dong, Yu Zheng, Michael D Hughes, et al.
Pageof 4